William Blair & Company’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.71M | Sell |
|
|||||
|
2025
Q1 | $2.32M | Sell |
|
|||||
|
2024
Q4 | $4.5M | Sell |
|
|||||
|
2024
Q3 | $5.73M | Sell |
|
|||||
|
2024
Q2 | $7.29M | Sell |
|
|||||
|
2024
Q1 | $10.1M | Buy |
|
|||||
|
2023
Q4 | $8.56M | Buy |
|
|||||
|
2023
Q3 | $6.03M | Buy |
|
|||||
|
2023
Q2 | $7.46M | Buy |
|
|||||
|
2023
Q1 | $5.84M | Buy |
|
|||||
|
2022
Q4 | $3.24M | Sell |
|
|||||
|
2022
Q3 | $5.4M | Buy |
|
|||||
|
2022
Q2 | $4.89M | Sell |
|
|||||
|
2022
Q1 | $7.18M | Buy |
|
|||||
|
2021
Q4 | $6.97M | Sell |
|
|||||
|
2021
Q3 | $10.6M | Buy |
|
|||||
|
2021
Q2 | $14.2M | Buy |
|
|||||
|
2021
Q1 | $9.81M | Buy |
|
|||||
|
2020
Q4 | $10.8M | Buy |
|
|||||
|
2020
Q3 | $5.83M | Buy |
|
|||||
|
2020
Q2 | $4.87M | Sell |
|
|||||
|
2020
Q1 | $2.85M | Sell |
|
|||||
|
2019
Q4 | $4.3M | Buy |
|
|||||
|
2019
Q3 | $2.44M | Sell |
|
|||||
|
2019
Q2 | $2.9M | Buy |
|
|||||
|
2019
Q1 | $544K | Buy |
|
|||||
|
2018
Q4 | $432K | Buy |
|
|||||
|
2018
Q3 | $618K | Sell |
|
|||||
|
2018
Q2 | $922K | Buy |
|
|||||
|
2018
Q1 | $709K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $277K | Buy |
|